Guidance for industry : revised preventive measures to reduce the possible risk of transmission of Creutzfeldt-Jakob disease (CJD) and variant Creutzfeldt-Jakob disease (vCJD) by blood and blood products.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2002]
Subjects:	Creutzfeldt-Jakob disease > United States > Prevention. Blood > Transfusion > Government policy > United States. Blood products > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112744

Description
Item Description:	Title from PDF title page (viewed on May 18, 2009). "January 2002". Includes bibliographical references (pages 27-28). Electronic resource.
Physical Description:	i, 33 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/18/09: http://www.fda.gov/cber/gdlns/cjdvcjd.pdf ; current access is available via PURL.